NCT00062296 2013-07-11Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaFox Chase Cancer CenterPhase 2 Completed5 enrolled